Dimethyloxalylglycine stabilizes HIF-1α in cultured human endothelial cells and increases random-pattern skin flap survival in vivo

Plastic and Reconstructive Surgery

Volumn 128, Issue 2, 2011, Pages 415-422

  Shafighi, Maziar ^a   Olariu, Radu ^a   Fathi, Ali R ^a   Djafarzadeh, Siamak ^a   Jakob, Stephan M ^a   Banic, Andrej ^a   Constantinescu, Mihai A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DICARBOXYLIC AMINO ACID; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXALYLGLYCINE;

ANIMAL; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GRAFT SURVIVAL; HUMAN; LASER DOPPLER FLOWMETRY; MALE; METABOLISM; PLASTIC SURGERY; RAT; SKIN TRANSPLANTATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION; WISTAR RAT;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LASER-DOPPLER FLOWMETRY; MALE; RATS; RATS, WISTAR; SKIN TRANSPLANTATION; SURGICAL FLAPS; UMBILICAL VEINS;

EID: 80051519799     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31821e6e69     Document Type: Article

References (39)

1. Morris SF, Taylor GI. The time sequence of the delay phenomenon: When is surgical delay effective? An experimental study. Plast Reconstr Surg. 1995;95:526-533.
2. Shalom A, Friedman T, Westreich M. The effect of postoperative aspirin on random pattern flaps in rats. Am Surg. 2007;73:1126-1128. (Pubitemid 351396520)
3. Emery FM, Kodey TR, Bomberger RA, McGregor DB. The effect of nifedipine on skin-flap survival. Plast Reconstr Surg. 1990;85:61-63. (Pubitemid 20029127)
4. Miyawaki T, Jackson IT, Bier UC, Andrus L, Williams F, Bradford M. The effect of capsaicin ointment on skin for the survival of a cutaneous flap. Eur J Plast Surg. 2001;24:28-30. (Pubitemid 32219771)
5. Huemer GM, Wechselberger G, Otto-Schoeller A, Gurunluoglu R, Piza-Katzer H, Schoeller T. Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamide and nicoboxil. Plast Reconstr Surg. 2003;111:1207-1211. (Pubitemid 36297421)
6. Karacaogilan N, Akbaş H. Effect of parenteral pentoxifylline and topical nitroglycerin on skin flap survival. Otolaryngol Head Neck Surg. 1999;120:272-274.
7. Akhavani MA, Sivakumar B, Paleolog EM, Kang N. Angiogenesis and plastic surgery. J Plast Reconstr Aesthet Surg. 2008; 61:1425-1437.
8. Gurunluoglu R, Meirer R, Shafighi M, Huemer GM, Yilmaz B, Piza-Katzer H. Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication. Microsurgery 2005; 25:433-441. (Pubitemid 41098674)
9. Huemer GM, Shafighi M, Meirer R, Debagge P, Piza-Katzer H, Gurunluoglu R. Adenovirus-mediated transforming growth factor-beta ameliorates ischemic necrosis of epigastric skin flaps in a rat model. J Surg Res. 2004;121:101-107. (Pubitemid 39094102)
10. Martorell L, Gentile M, Rius J, et al. The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia. Mol Cell Biol. 2009;29:5828-5842.
11. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem. 1996;271:17771-17778. (Pubitemid 26250751)
12. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-472. (Pubitemid 32335942)
13. Zhao HX, Wang XL, Wang YH, et al. Attenuation of myocardial injury by postconditioning: Role of hypoxia inducible factor-1alpha. Basic Res Cardiol. 2010;105:109-118.
14. Milkiewicz M, Pugh CW, Egginton S. Inhibition of endogenous HIF inactivation induces angiogenesis in ischemic skeletal muscles of mice. J Physiol. 2004;560:21-26. (Pubitemid 39406013)
15. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-1340. (Pubitemid 33063099)
16. McFarlane RM, DeYoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg. 1965;35:177-182.
17. Rinsch C, Quinodoz P, Pittet B, et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther. 2001;8:523-533. (Pubitemid 32409527)
18. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol. 1996;16:4604-4613. (Pubitemid 26272112)
19. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004;25:581-611. (Pubitemid 39099316)
20. Hart K, Baur D, Hodam J, et al. Short-and long-term effects of sildenafil on skin flap survival in rats. Laryngoscope 2006; 116:522-528. (Pubitemid 44318059)
21. Sarifakioglu N, Gokrem S, Ates L, Akbuga UB, Aslan G. The influence of sildenafil on random skin flap survival in rats: An experimental study. Br J Plast Surg. 2004;57:769-772. (Pubitemid 39497130)
22. Tyner TR, Shahbazian R, Nakashima J, Kane S, Sian K, Yamaguchi KT. Propofol improves skin flap survival in a rat model: Correlating reduction in flap-induced neutrophil activity. Ann Plast Surg. 2004;53:273-277. (Pubitemid 39278820)
23. Askar I, Bozkurt M, Oktay MF, Gürlek A, Keles C. Salutary effects of radiopaque contrast media on the survival of random-pattern skin flaps in the rat: An experimental study. Microsurgery 2004;24:81-84. (Pubitemid 38174361)
24. Bayati S, Russell RC, Roth AC. Stimulation of angiogenesis to improve the viability of prefabricated flaps. Plast Reconstr Surg. 1998;101:1290-1295. (Pubitemid 28152705)
25. Fujihara Y, Koyama H, Ohba M, et al. Controlled delivery of bFGF to recipient bed enhances the vascularization and viability of an ischemic skin flap. Wound Repair Regen. 2008; 16:125-131.
26. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998;98: 2081-2087. (Pubitemid 28512235)
27. Jung H, Gurunluoglu R, Scharpf J, Siemionow M. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 2003;23:374-380. (Pubitemid 37093607)
28. Clover AJ, McCarthy MJ. Developing strategies for therapeutic angiogenesis: Vascular endothelial growth factor alone may not be the answer. Br J Plast Surg. 2003;56:314. (Pubitemid 36926660)
29. Risau W. Mechanisms of angiogenesis. Nature 1997;386: 671-674. (Pubitemid 27193480)
30. Asahara T, Chen D, Takahashi T, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res. 1998;83:233-240. (Pubitemid 28371312)
31. Chae JK, Kim I, Lim ST, et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol. 2000; 20:2573-2578.
32. Benest AV, Salmon AH, Wang W, et al. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Microcirculation 2006;13:423-437. (Pubitemid 44322159)
33. Patel TH, Kimura H, Weiss CR, Semenza GL, Hofmann LV. Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res. 2005;68:144-154. (Pubitemid 41253565)
34. Pajusola K, Kunnapuu J, Vuorikoski S, et al. Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J. 2005; 19:1365-1367. (Pubitemid 41113751)
35. Chang EI, Loh SA, Ceradini DJ, et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 2007;116:2818-2829. (Pubitemid 350291224)
36. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem. 2003;279: 30772-30780. (Pubitemid 36994584)
37. Nangaku M, Izuhara Y, Tazikawa S, et al. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol. 2007;27:2548-2554. (Pubitemid 350158904)
38. Asikainen TM, Ahmad A, Schneider BK, et al. Stimulation of HIF-1alpha, HIF-2alpha, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells. Free Radic Biol Med. 2005;38:1002-1013. (Pubitemid 40386546)
39. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHLmediated destruction by proline hydroxylation: Implications for O2 sensing. Science 2001;292:464-468. (Pubitemid 32335941)